Expression of monocyte chemoattractant protein-1 in the lesional skin of systemic sclerosis

Journal of Dermatological Science

Volumn 26, Issue 2, 2001, Pages 133-139

  Yamamoto, Toshiyuki ^a,b   Eckes, Beate ^a   Hartmann, Karin ^a   Krieg, Thomas ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Chemokine; Monocyte chemoattractant protein 1; Systemic sclerosis

Indexed keywords

MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTACT DERMATITIS; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; KERATINOCYTE; MALE; MONOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN; SKIN FIBROBLAST; SYSTEMIC SCLEROSIS;

ADULT; CHEMOKINE CCL2; FEMALE; FIBROBLASTS; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; MACROPHAGES; MALE; MIDDLE AGED; MONOCYTES; RNA, MESSENGER; SCLERODERMA, SYSTEMIC; SKIN;

EID: 0034988135     PISSN: 09231811     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0923-1811(00)00169-9     Document Type: Article

References (32)

1. Systemic scleroderma. Clinical and pathophysiological aspects
2. Scleroderma (systemic sclerosis): Classification, subsets and pathogenesis
3. Fibroblast selection in scleroderma: An alternative model of fibrosis
4. Scleroderma: A model for fibrosis
5. Identification of fibroblasts responsible for increased collagen production in localized scleroderma by in situ hybridization
6. Localization of collagen mRNA in normal and scleroderma skin by in-situ hybridization
7. Cytokines and systemic sclerosis
8. Connective tissue metabolism including cytokine in scleroderma
9. Cellular infiltrates in scleroderma skin
10. Fibrogenic cytokines: The role of immune mediators in the development of fibrosis
11. Fibrogenic cytokines and connective tissue production
12. A strategy for determining the pathogenesis of systemic sclerosis. Is transforming growth factor the answer?
13. Transforming growth factor type β: Rapid induction of fibroblasts and angiogenesis in vivo and stimulation of collagen formation in vitro
14. Transforming growth factor β (TGF β) causes a persistent increase in steady-state amounts of type I and type III collagen and fibronectin mRNAs in normal human dermal fibroblasts
15. Transforming growth factor-β increases steady state levels of type I procollagen and fibronectin messenger RNAs posttranscriptionally in cultured human dermal fibroblasts
16. Transforming growth factor-β stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix
17. Co-localization of transforming growth factor β2 with α1(I) procollagen mRNA in tissue sections of patients with systemic sclerosis
18. Evaluation of transforming growth factor β and type I procollagen gene expression in fibrotic skin diseases by in situ hybridization
19. Transcription and expression of transforming growth factor type beta in the skin of progressive systemic sclerosis: A mediator of fibrosis
20. Human monocyte chemoattractant protein-1 (MCP-1)
21. Cloning and expression of JE, a gene inducible by platelet-derived growth factor and whose product has cytokine-like properties
22. Purification and amino acid analysis of two human monocyte chemoattractants produced by phytohemagglutinin-stimulated human blood mononuclear leukocytes
23. Secretion by human fibroblasts of monocyte chemoattractant protein-1, the product of gene JE
24. Alveolar macrophage-derived cytokines induce monocyte chemoattractant protein-1 expression from human pulmonary type II-like epithelial cells
25. Molecular cloning of rat monocyte chemoattractant protein-1 (MCP-1) and its expression in rat spleen cells and tumor cell lines
26. Lung monocyte chemoattractant protein-1 gene expression in bleomycin-induced pulmonary fibrosis
27. RANTES and monocyte chemoattractant protein-1 (MCP-1) play an important role in the inflammatory phase of crescent nephritis, but only MCP-1 is involved in crescent formation and interstitial fibrosis
28. Costimulation of fibroblast collagen and transforming growth factor β1 gene expression by monocyte chemoattractant protein-1 via specific receptors
29. Macrophage infiltration in the skin of patients with systemic sclerosis
30. Augmented production of chemokines (monocyte chemotactic protein-1 (MCP-1), macrophage inflammatory protein-1α (MIP-1α) and MIP-1β) in patients with systemic sclerosis: MCP-1 and MIP-1α may be involved in the development of pulmonary fibrosis
31. Monocyte chemoattractant protein-1 is sufficient for the chemotaxis of monocytes and lymphocytes in transgenic mice but requires an additional stimulus for inflammatory activation